Poster session 12

Programme

• 15:30 – 15:35 3 Min. 2 Min.

  • ePoster
  • P120a

  Evaluation of PREEMPT fixed-dose, fixed-site and follow the pain treatment paradigms in the PREDICT Study

  • Laurent Delahaye

   Migraine
• 15:35 – 15:40 3 Min. 2 Min.

  • ePoster
  • P121

  The virtual "Enfacement Illusion" on pain perception in patients suffering from chronic migraine: Preliminary data from a randomized controlled trial

  • Sara Bottiroli (Pavia/ IT)

   Migraine, Multidisciplinary clinical assessments
• 15:40 – 15:45 3 Min. 2 Min.

  • ePoster
  • P122

  Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study

  • Susan Hutchinson (Irvine/ US)
  • Christopher M. Jensen (New Haven/ US)

   CGRP inhibitors in the clinic, Migraine
• 15:45 – 15:50 3 Min. 2 Min.

  • ePoster
  • P123

  Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine

  • Christopher M. Jensen (New Haven/ US)

   CGRP inhibitors in the clinic, Migraine
• 15:50 – 15:55 3 Min. 2 Min.

  • ePoster
  • P124

  Characterizing gaps in preventive treatment of migraine: global results from the CaMEO-International study

  • Manjit Matharu (London/ GB)

   Migraine
• 15:55 – 16:00 3 Min. 2 Min.

  • ePoster
  • P125

  Concomitant treatment of anti-CGRP and botulinum toxin in resistant migraine, is it useful for our patients?

  • Candela Nieves Castellanos (Valencia/ ES)

   CGRP inhibitors in the clinic, Migraine
• 16:00 – 16:05 3 Min. 2 Min.

  • ePoster
  • P126

  The effect or resveratrol in ex vivo and behavioral rat models of migraine

  • Philip Reducha (Copenhagen/ DK)

   Basic science, animal models in headache research, Migraine
• 16:05 – 16:10 3 Min. 2 Min.

  • ePoster
  • P127

  Is migraine causally linked to inflammatory bowel disease or coeliac disease? A Mendelian randomisation study

  • Nike Welander (Uppsala/ SE)

   Genetics genomics | RNA, Migraine
• 16:10 – 16:15 3 Min. 2 Min.

  • ePoster
  • P128

  Medication overuse and patient-reported outcome of OnabotulinumtoxinA treatment in Chronic Migraine

  • Catarina Fernandes (Coimbra/ PT)

   Migraine, Neuromodulation and nerve blocks
• 16:15 – 16:20 3 Min. 2 Min.

  • ePoster
  • P129

  Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study

  • Peter J. Goadsby (London/ GB)

   Migraine
• 16:20 – 16:25 3 Min. 2 Min.

  • ePoster
  • P130

  Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine – a randomized controlled trial

  • Ruth Meise (Luebeck/ DE)

   Migraine
• 16:25 – 16:30 3 Min. 2 Min.

  • ePoster
  • P131

  Assessing Hypersensitivity, Cortical Hyperexcitability, and Habituation in Migraine, according to Age and Disease Severity, using Visual Evoked Potentials during Pattern-Reversal Stimulation

  • Angela Marti-Marca (Barcelona/ ES)

   Migraine
• 16:30 – 16:35 3 Min. 2 Min.

  • ePoster
  • P132

  Effects of vitamin B1, B6, and B12 on serum levels of CGRP, endothelial nitric-oxide synthase, homocysteine, and headache characteristics in women with episodic migraine

  • Shiva Nematgorgani (Tehran/ IR)

   Migraine
• 16:35 – 16:40 3 Min. 2 Min.

  • ePoster
  • P133

  Quantifying aversion thresholds to light, sound, smell, and touch in migraine: A longitudinal study in migraine and non-headache controls

  • Nara Ikumi (Barcelona/ ES)

   Basic science, animal models in headache research, Migraine
• 16:40 – 16:45 3 Min. 2 Min.

  • ePoster
  • P134

  Negative impact of under-diagnosed migraine in university students in Slovakia

  • Oľga Duraníková (Bratislava/ SK)
  • Simona Horváthová (Bratislava/ SK)

   Epidemiology, Migraine
• 16:45 – 16:50 3 Min. 2 Min.

  • ePoster
  • P135

  Change in Migraine Diagnosis After Preventive Treatment With Eptinezumab: Post Hoc Analysis of the PROMISE Studies

  • Patricia Pozo-Rosich (Barcelona/ ES)

   Migraine
• 16:50 – 16:55 3 Min. 2 Min.

  • ePoster
  • P136

  Hormonal treatment for menstrual migraine: rationale and protocol of the WHAT!-Trial

  • Britt van der Arend (Leiden/ NL)

   Headache, hormones and dietary, Migraine
• 16:55 – 17:00 3 Min. 2 Min.

  • ePoster
  • P137

  Identification of crystal-clear days in migraine using data of a nation-wide population-based study

  • Wonwoo Lee (Yongin/ KR)

   Epidemiology, Migraine